VEGFA and vitreous hemorrhage: The model revealed key molecular pathways involved in NIV pathology, such as persistently elevated VEGF levels in mid-stage NIV patients, which correlated with disease progression—suggesting that anti-VEGF injections could alleviate vitreous hemorrhage without requiring vitrectomy.